AbstractGet full access to this articleView all access options for this article.Get accessReferences1. DiMasi JA Kim J Getz KA . The impact of collaborative and risk-sharing innovation approaches on clinical and regulatory cycle times. Therapeutic Innovation & Regulatory Science. 2014;48(3):482–487.
